|
|
|
市場調查報告書
全身性硬化症(硬皮症):全球臨床實驗檢討(2012年前半期)
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品編碼 |
228197 |
| 內容資訊 |
英文 Pages: 95 |
| 價格 |
|
|
全身性硬化症(硬皮症):全球臨床實驗檢討(2012年前半期) 是由出版商GlobalData在2012年01月所出版的。
這份英文市場調查報告書包含Pages: 95 價格從美金1000起跳。
本報告提供全身性硬皮症(皮膚硬化症)相關臨床研究的最新趨勢分析，以疾患概要為首，提供G7各國、BRIC各國、E7各國的實驗情況，各地、各期、各階段的進行狀況，有潛力贊助商、各企業及研究機關的研究進行狀況、有潛力藥劑的比較等資訊，為您概述為以下內容。
目錄
簡介
各地區的臨床實驗
- 各國臨床實驗數量
- 亞太地區臨床實驗數量前幾名國家
- 歐洲的臨床實驗數量前五名國家
- 北美臨床實驗數量前幾名國家
- 中東·北非的臨床實驗數量前幾名國家
- 中南美的臨床實驗數量前幾名國家
金磚5國各國的臨床實驗
G7各國的臨床實驗
G7各國的臨床實驗:各進展狀況
E7各國的臨床實驗
E7各國的臨床實驗:各進展狀況
不同階段臨床實驗情形
各階段臨床實驗情形
尚未完成的臨床實驗
一定期間內採用的實驗人數
有潛力的贊助商
有潛力的藥劑比較分析
臨床實驗簡介
- 前幾名企業臨床實驗概要
- Actelion Ltd
- United Therapeutics Corporation
- MediQuest Therapeutics, Inc.
- Benesis Corporation
- MedImmune, LLC
- Roche Nederland B.V.
- Daval International Ltd.
- Amira Pharmaceuticals, Inc
- Italfarmaco S.p.A.
- Active Biotech AB
- Novartis AG
- Merck & Co., Inc
- Allergan, Inc.
- Genzyme Corporation
- Bristol-Myers Squibb Company
- 前幾名大學·研究機關·醫院臨床實驗概要
- Fred Hutchinson Cancer Research Center
- The National Institute of Allergy and Infectious Diseases
- Rouen University Hospital
- University of Michigan
- Johns Hopkins University
- Assistance Publique - Hopitaux de Paris
- Stanford University
- University of California, Los Angeles
- Hospital for Special Surgery
- University of Medicine and Dentistry New Jersey
- Duke University
- Boston University
- Federal University of Sao Paulo
- Charite University
- Georgetown University
- Northwestern University
- University of Dundee
- Ghent University Hospital
- Universita' Politecnica delle Marche
- Alexandria University
5個有代表性的臨床實驗簡介
附錄
圖表一覽
Abstract
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, "Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" provides data on the Systemic Sclerosis (Scleroderma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Sclerosis (Scleroderma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Sclerosis (Scleroderma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
TOC
Table of Contents
Table of Contents 2
- List of Tables 5
- List of Figures 7
- Introduction 8
- Systemic Sclerosis (Scleroderma) 8
- Report Guidance 8
- Clinical Trials by Region 9
- Clinical Trials by Country 10
- Top Countries Contributing to Clinical Trials in Asia-Pacific 12
- Top Five Countries Contributing to Clinical Trials in Europe 13
- Top Countries Contributing to Clinical Trials in North America 14
- Top Countries Contributing to Clinical Trials in Middle East and Africa 15
- Top Countries Contributing to Clinical Trials in Central and South America 16
- Clinical Trials by BRIC Nations 17
- Clinical Trials by G7 Nations 18
- Clinical Trials in G7 Nations by Trial Status 19
- Clinical Trials by E7 Nations 20
- Clinical Trials in E7 Nations by Trial Status 21
- Clinical Trials by Phase 22
- In Progress Trials by Phase 23
- Clinical Trials by Trial Status 24
- Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 25
- Subjects Recruited Over a Period of Time 27
- Prominent Sponsors 28
- Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 30
- Prominent Drug Comparison 32
- Clinical Trial Profiles 33
- Clinical Trial Overview of Top Companies 33
- Actelion Ltd 33
- Clinical Trial Overview of Actelion Ltd 33
- United Therapeutics Corporation 34
- Clinical Trial Overview of United Therapeutics Corporation 34
- MediQuest Therapeutics, Inc. 35
- Clinical Trial Overview of MediQuest Therapeutics, Inc. 35
- Benesis Corporation 36
- Clinical Trial Overview of Benesis Corporation 36
- MedImmune, LLC 37
- Clinical Trial Overview of MedImmune, LLC 37
- Roche Nederland B.V. 38
- Clinical Trial Overview of Roche Nederland B.V. 38
- Daval International Ltd. 39
- Clinical Trial Overview of Daval International Ltd. 39
- Amira Pharmaceuticals, Inc. 40
- Clinical Trial Overview of Amira Pharmaceuticals, Inc. 40
- Italfarmaco S.p.A. 41
- Clinical Trial Overview of Italfarmaco S.p.A. 41
- Active Biotech AB 42
- Clinical Trial Overview of Active Biotech AB 42
- Novartis AG 43
- Clinical Trial Overview of Novartis AG 43
- Merck & Co., Inc. 44
- Clinical Trial Overview of Merck & Co., Inc. 44
- Allergan, Inc. 45
- Clinical Trial Overview of Allergan, Inc. 45
- Genzyme Corporation 46
- Clinical Trial Overview of Genzyme Corporation 46
- Bristol-Myers Squibb Company 47
- Clinical Trial Overview of Bristol-Myers Squibb Company 47
- Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
- Fred Hutchinson Cancer Research Center 48
- Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48
- The National Institute of Allergy and Infectious Diseases 49
- Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 49
- Rouen University Hospital 50
- Clinical Trial Overview of Rouen University Hospital 50
- University of Michigan 51
- Clinical Trial Overview of University of Michigan 51
- Johns Hopkins University 52
- Clinical Trial Overview of Johns Hopkins University 52
- Assistance Publique - Hopitaux de Paris 53
- Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
- Stanford University 54
- Clinical Trial Overview of Stanford University 54
- University of California, Los Angeles 55
- Clinical Trial Overview of University of California, Los Angeles 55
- Hospital for Special Surgery 56
- Clinical Trial Overview of Hospital for Special Surgery 56
- University of Medicine and Dentistry New Jersey 57
- Clinical Trial Overview of University of Medicine and Dentistry New Jersey 57
- Duke University 58
- Clinical Trial Overview of Duke University 58
- Boston University 59
- Clinical Trial Overview of Boston University 59
- Federal University of Sao Paulo 60
- Clinical Trial Overview of Federal University of Sao Paulo 60
- Charite University 61
- Clinical Trial Overview of Charite University 61
- Georgetown University 62
- Clinical Trial Overview of Georgetown University 62
- Northwestern University 63
- Clinical Trial Overview of Northwestern University 63
- University of Dundee 64
- Clinical Trial Overview of University of Dundee 64
- Ghent University Hospital 65
- Clinical Trial Overview of Ghent University Hospital 65
- Universita' Politecnica delle Marche 66
- Clinical Trial Overview of Universita' Politecnica delle Marche 66
- Alexandria University 67
- Clinical Trial Overview of Alexandria University 67
- Five Key Clinical Profiles 68
Appendix 91
- Abbreviations 91
- Definitions 91
- Research Methodology 93
- Secondary Research 93
- About GlobalData 94
- Contact Us 94
- Disclaimer 94
- Source 95
List of Tables
List of Tables
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 12
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries, 2012* 18
- Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries, 2012* 20
- Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012* 33
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012* 34
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2012* 35
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Benesis Corporation, 2012* 36
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012* 37
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Nederland B.V., 2012* 38
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daval International Ltd., 2012* 39
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amira Pharmaceuticals, Inc., 2012* 40
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Italfarmaco S.p.A., 2012* 41
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2012* 42
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 43
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 44
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 45
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 46
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 47
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 48
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 49
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2012* 50
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012* 51
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 52
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 53
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 54
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 55
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital for Special Surgery, 2012* 56
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 57
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 58
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2012* 59
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 60
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 61
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2012* 62
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 63
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2012* 64
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2012* 65
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita' Politecnica delle Marche, 2012* 66
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2012* 67
List of Figures
List of Figures
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 12
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
- Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
- Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
- Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
- Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
- GlobalData Methodology 93
|
 |
